March 26, 2025 09:00 AM EDT
R&D

The End­points Slack in­ter­view: Duke’s Pranam Chat­ter­jee un­packs AI bio’s pret­ty pic­ture fal­la­cy

Andrew Dunn

Senior Biopharma Correspondent

The End­points News Slack chat is back for 2025, and we’re start­ing with a 32-year-old com­pu­ta­tion­al bi­ol­o­gy pro­fes­sor who isn’t afraid to share a hot …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

FDA's Pe­ter Marks re­signs, say­ing he won't ac­cept Kennedy's 'mis­in­for­ma­tion and lies'

Blue­bird gets new M&A bid, seek­ing to top pri­vate eq­ui­ty of­fer

Small biotech joins list of health com­pa­nies tak­ing a trip to Trump's Mar-a-La­go

‘Peo­ple will die’: End of NIH grants guts work be­tween aca­d­e­mics and com­pa­nies to counter next pan­dem­ic

No­vo Nordisk pays $200M up­front for Chi­na-based biotech’s triple-G obe­si­ty shot

BioN­Tech de­tails promis­ing mid-stage da­ta for its PD-L1xVEGF in ag­gres­sive lung can­cer

A service from the Financial Times